CAPTRUST Financial Advisors’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,603
| Closed | -$133K | – | 2503 |
|
|
2023
Q4 | $133K | Buy |
13,603
+736
| +6% | +$7.22K | ﹤0.01% | 2484 |
|
|
2023
Q3 | $107K | Buy |
12,867
+1,276
| +11% | +$10.7K | ﹤0.01% | 2422 |
|
|
2023
Q2 | $154K | Buy |
+11,591
| New | +$154K | ﹤0.01% | 2321 |
|
|
2022
Q3 | – | Sell |
-1,553
| Closed | -$7K | – | 3423 |
|
|
2022
Q2 | $7K | Sell |
1,553
-390
| -20% | -$1.76K | ﹤0.01% | 3938 |
|
|
2022
Q1 | $18K | Buy |
1,943
+919
| +90% | +$8.51K | ﹤0.01% | 3458 |
|
|
2021
Q4 | $21K | Sell |
1,024
-1,428
| -58% | -$29.3K | ﹤0.01% | 3256 |
|
|
2021
Q3 | $63K | Buy |
2,452
+144
| +6% | +$3.7K | ﹤0.01% | 2429 |
|
|
2021
Q2 | $81K | Sell |
2,308
-327
| -12% | -$11.5K | ﹤0.01% | 2187 |
|
|
2021
Q1 | $88K | Buy |
+2,635
| New | +$88K | ﹤0.01% | 2050 |
|